Medtech Insight

Insulet, Ypsomed Split Up And Go Head-To-Head In Insulin Pump Market

21 Jul 2017

Insulin pump commercial partners Insulet and Ypsomed will be parting ways after some eight years in an exclusive distribution alliance. The companies failed to reach an agreement to renew the distributor agreement, which will end June 2018, following differences on price. Ypsomed announced it will introduce its own tubeless insulin pump in the mid-term.

Massachusetts-based maker of the Omnipod insulin patch pumpInsulet Corp. has announced it will split from its European distributor Ypsomed from June 30, 2018 and take complete ownership of its insulin patch pump – the Omnipod Insulin Management System.

Ypsomed has held exclusive rights to distribute the Omnipod in Europe and other markets outside the US since 2010. During...